|Page (1) of 1 - 02/15/12||email article||print page|
A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc(February 15, 2012)
HONG KONG -- (Marketwire) -- 02/15/12 -- Today, www.BollingerReport.com introduced featured coverage of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) and Cubist Pharmaceuticals Inc (NASDAQ: CBST). Full research reports are available to readers at: www.BollingerReport.com/index.php?sm1=MNTA&sm2=CBST.
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential - there remains strong opportunity within careful discretion.
Bollinger Report screened and selected Momenta Pharmaceuticals, Inc. for its current position within the healthcare industry. Momenta Pharmaceuticals, Inc. (Momenta) is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). A copy of this report featuring Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) is available at: www.BollingerReport.com/index.php?sm1=MNTA.
Bollinger Report is featuring Cubist Pharmaceuticals Inc for its changing role within the healthcare industry. Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The Company's products are used primarily in hospitals, but also may be used in acute care settings, including home infusion and hospital outpatient clinics. To download researches and analysis on Cubist Pharmaceuticals Inc (NASDAQ: CBST) we welcome investors to visit: www.BollingerReport.com/index.php?sm2=CBST.
About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.
Copyright @ Marketwire
Related Keywords: Bollinger Report, USA,Marketwire, Inc., ,Healthcare,Biotechnology,Hospitals,Medical,